Memphis Pharmaceuticals (Egypt) Price on December 4, 2024

MPCI Stock   51.98  0.27  0.52%   
If you're considering investing in Memphis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Memphis Pharmaceuticals stands at 51.98, as last reported on the 25th of December, with the highest price reaching 52.98 and the lowest price hitting 51.71 during the day. Memphis Pharmaceuticals appears to be not too volatile, given 3 months investment horizon. Memphis Pharmaceuticals has Sharpe Ratio of 0.12, which conveys that the firm had a 0.12% return per unit of risk over the last 3 months. By analyzing Memphis Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.84% is justified by implied risk. Please exercise Memphis Pharmaceuticals' Downside Deviation of 3.09, mean deviation of 3.23, and Risk Adjusted Performance of 0.0933 to check out if our risk estimates are consistent with your expectations.
  
Memphis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1166

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsMPCI
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 7.19
  actual daily
64
64% of assets are less volatile

Expected Return

 0.84
  actual daily
16
84% of assets have higher returns

Risk-Adjusted Return

 0.12
  actual daily
9
91% of assets perform better
Based on monthly moving average Memphis Pharmaceuticals is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Memphis Pharmaceuticals by adding it to a well-diversified portfolio.

Memphis Pharmaceuticals Valuation on December 4, 2024

It is possible to determine the worth of Memphis Pharmaceuticals on a given historical date. On December 4, 2024 Memphis was worth 50.01 at the beginning of the trading date compared to the closed value of 49.95. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Memphis Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Memphis Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Memphis Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Memphis Pharmaceuticals' related companies.
 Open High Low Close Volume
  51.74    53.00    49.00    50.01    68,648  
12/04/2024
  50.01    52.99    49.90    49.95    96,286  
  49.95    53.90    49.95    51.50    114,148  
Backtest Memphis Pharmaceuticals  |  Memphis Pharmaceuticals History  PreviousNext  
Open Value
50.01
49.95
Closing Value
71.59
Upside

Memphis Pharmaceuticals Trading Date Momentum on December 4, 2024

On December 05 2024 Memphis Pharmaceuticals was traded for  51.50  at the closing time. The highest price during the trading period was 53.90  and the lowest recorded bid was listed for  49.95 . The volume for the day was 114.1 K. This history from December 5, 2024 contributed to the next trading day price rise. The trading delta at closing time to the next closing price was 3.10% . The trading delta at closing time to the current price is 10.85% .

Price Boundaries

Memphis Pharmaceuticals Period Price Range

Low
December 25, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Memphis Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on Egyptian Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Memphis Pharmaceuticals December 25, 2024 Market Strength

Market strength indicators help investors to evaluate how Memphis Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Memphis Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Memphis Pharmaceuticals stock market strength indicators, traders can identify Memphis Pharmaceuticals entry and exit signals to maximize returns

Memphis Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Memphis Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Memphis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Memphis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Memphis Stock analysis

When running Memphis Pharmaceuticals' price analysis, check to measure Memphis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Memphis Pharmaceuticals is operating at the current time. Most of Memphis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Memphis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Memphis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Memphis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bonds Directory
Find actively traded corporate debentures issued by US companies
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Valuation
Check real value of public entities based on technical and fundamental data